ESPEROCT
Live / Registered — Registered — Section 71 accepted (as of 05 Nov 2025)
What this means for you
Registered since 10 Mar 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79152765
- Registration number
- 4697829
- Mark type
- Stylized text
- Filed
- 24 Jul 2014
- Published for opposition
- 23 Dec 2014
- Registered
- 10 Mar 2015
- Attorney of record
- /Spencer Beall/
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for hemostasis management
Owner
- Novo Nordisk Health Care AG, Zürich, CH
- Novo Nordisk Health Care AG, CH
- Novo Nordisk Health Care AG, CH
Prosecution history
- 05 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 05 Nov 2025 — REGISTERED-SEC.71 ACCEPTED
- 17 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 31 Mar 2025 — POST REGISTRATION ACTION MAILED - SEC.71
- 11 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Oct 2024 — TEAS SECTION 71 RECEIVED
- 02 May 2024 — INTERNATIONAL REGISTRATION RENEWED
- 10 Mar 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 04 Dec 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 21 Nov 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Aug 2021 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 20 Jan 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 19 Jan 2021 — REGISTERED-SEC.71 ACCEPTED
- 08 Jan 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Sept 2020 — TEAS SECTION 71 RECEIVED